US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist
  • 5.050
  • +0.170+3.48%
Close Nov 27 16:00 ET
54.50MMarket Cap-1162P/E (TTM)

Elicio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-40.29%-7.27M
5.77%-8.93M
-48.94%-12.12M
-47.41%-32.69M
-36.00%-9.9M
3.73%-5.19M
-9.48M
-8.14M
7.35%-22.18M
-7.28M
Net income from continuing operations
-76.72%-18.84M
4.34%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.10%-10.66M
---7.56M
---8.03M
-6.85%-28.21M
---6.65M
Operating gains losses
9,175.51%9.09M
-301.33%-3.62M
1,815.74%1.85M
-197.89%-927K
-102.44%-16K
-72.78%98K
---901K
---108K
1,688.07%947K
--657K
Depreciation and amortization
6.23%290K
-41.52%293K
163.64%290K
10.69%1.17M
-2.72%286K
-7.14%273K
--501K
--110K
320.36%1.06M
--294K
Other non cash items
----
----
----
-68.41%1.14M
-12.64%76K
-100.09%-1K
--719K
--342K
439.09%3.6M
--87K
Change In working capital
-63.03%1.76M
150.64%1.27M
-307.37%-2.76M
62.00%-57K
12.51%-1.63M
15,986.67%4.77M
---2.52M
---678K
-117.19%-150K
---1.86M
-Change in prepaid assets
-44.00%588K
-146.58%-180K
222.30%1.25M
61.04%-729K
-45.76%-688K
170.14%1.05M
---73K
---1.02M
-419.42%-1.87M
---472K
-Change in payables and accrued expense
-81.72%421K
248.13%1.99M
-465.94%-3.7M
173.05%2.24M
151.45%266K
533.71%2.3M
---1.34M
--1.01M
-34.98%820K
---517K
-Change in other current liabilities
18.73%-204K
-45.98%-254K
-49.69%-244K
-54.21%-825K
-50.96%-237K
-62.99%-251K
---174K
---163K
-21.75%-535K
---157K
-Change in other working capital
-42.49%957K
70.18%-277K
86.79%-67K
-151.67%-742K
-35.47%-970K
--1.66M
---929K
---507K
--1.44M
---716K
Cash from discontinued investing activities
Operating cash flow
-40.29%-7.27M
5.77%-8.93M
-48.94%-12.12M
-47.41%-32.69M
-36.00%-9.9M
3.73%-5.19M
---9.48M
---8.14M
7.35%-22.18M
---7.28M
Investing cash flow
Cash flow from continuing investing activities
0
-240.00%-42K
117.65%3K
95.11%-32K
0
-45K
30K
-17K
-24.49%-654K
-95K
Net PPE purchase and sale
--0
-240.00%-42K
117.65%3K
95.11%-32K
--0
---45K
--30K
---17K
-24.49%-654K
---95K
Cash from discontinued investing activities
Investing cash flow
--0
-240.00%-42K
117.65%3K
95.11%-32K
--0
---45K
--30K
---17K
-24.49%-654K
---95K
Financing cash flow
Cash flow from continuing financing activities
51,156.67%30.75M
-98.53%316K
9.80%11.02M
82.12%38.61M
-37.36%7M
-99.32%60K
21.51M
10.04M
9.32%21.2M
11.18M
Net issuance payments of debt
--19.73M
--0
--0
--10M
--0
--0
--0
--10M
--0
--0
Net common stock issuance
--48K
302.00%303K
--5.06M
--6.85M
--7M
--0
---150K
--0
--0
--0
Net preferred stock issuance
----
----
----
--0
----
----
----
----
327.07%21.12M
--11.11M
Proceeds from stock option exercised by employees
19,113.33%11.53M
-51.85%13K
14,805.00%5.96M
54.88%127K
--0
198.36%60K
--27K
--40K
-21.36%82K
--65K
Net other financing activities
----
----
----
--21.64M
--2K
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
51,156.67%30.75M
-98.53%316K
9.80%11.02M
82.12%38.61M
-37.36%7M
-99.32%60K
--21.51M
--10.04M
9.32%21.2M
--11.18M
Net cash flow
Beginning cash position
-79.83%4.51M
28.24%13.21M
69.97%14.3M
-16.24%8.41M
273.07%17.2M
1,739.06%22.36M
--10.3M
--8.41M
-33.54%10.05M
--4.61M
Current changes in cash
554.16%23.48M
-171.72%-8.65M
-158.12%-1.1M
460.94%5.89M
-176.06%-2.89M
-252.37%-5.17M
--12.07M
--1.88M
67.84%-1.63M
--3.81M
Effect of exchange rate changes
1,700.00%36K
----
----
--0
--0
--2K
----
----
--0
--0
End cash Position
63.00%28.03M
-79.83%4.51M
28.24%13.21M
69.97%14.3M
69.97%14.3M
273.07%17.2M
--22.36M
--10.3M
-16.23%8.41M
--8.41M
Free cash flow
-39.08%-7.27M
5.37%-8.97M
-48.63%-12.12M
-43.48%-32.76M
-34.24%-9.9M
2.90%-5.23M
---9.48M
---8.16M
6.67%-22.83M
---7.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -40.29%-7.27M5.77%-8.93M-48.94%-12.12M-47.41%-32.69M-36.00%-9.9M3.73%-5.19M-9.48M-8.14M7.35%-22.18M-7.28M
Net income from continuing operations -76.72%-18.84M4.34%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.10%-10.66M---7.56M---8.03M-6.85%-28.21M---6.65M
Operating gains losses 9,175.51%9.09M-301.33%-3.62M1,815.74%1.85M-197.89%-927K-102.44%-16K-72.78%98K---901K---108K1,688.07%947K--657K
Depreciation and amortization 6.23%290K-41.52%293K163.64%290K10.69%1.17M-2.72%286K-7.14%273K--501K--110K320.36%1.06M--294K
Other non cash items -------------68.41%1.14M-12.64%76K-100.09%-1K--719K--342K439.09%3.6M--87K
Change In working capital -63.03%1.76M150.64%1.27M-307.37%-2.76M62.00%-57K12.51%-1.63M15,986.67%4.77M---2.52M---678K-117.19%-150K---1.86M
-Change in prepaid assets -44.00%588K-146.58%-180K222.30%1.25M61.04%-729K-45.76%-688K170.14%1.05M---73K---1.02M-419.42%-1.87M---472K
-Change in payables and accrued expense -81.72%421K248.13%1.99M-465.94%-3.7M173.05%2.24M151.45%266K533.71%2.3M---1.34M--1.01M-34.98%820K---517K
-Change in other current liabilities 18.73%-204K-45.98%-254K-49.69%-244K-54.21%-825K-50.96%-237K-62.99%-251K---174K---163K-21.75%-535K---157K
-Change in other working capital -42.49%957K70.18%-277K86.79%-67K-151.67%-742K-35.47%-970K--1.66M---929K---507K--1.44M---716K
Cash from discontinued investing activities
Operating cash flow -40.29%-7.27M5.77%-8.93M-48.94%-12.12M-47.41%-32.69M-36.00%-9.9M3.73%-5.19M---9.48M---8.14M7.35%-22.18M---7.28M
Investing cash flow
Cash flow from continuing investing activities 0-240.00%-42K117.65%3K95.11%-32K0-45K30K-17K-24.49%-654K-95K
Net PPE purchase and sale --0-240.00%-42K117.65%3K95.11%-32K--0---45K--30K---17K-24.49%-654K---95K
Cash from discontinued investing activities
Investing cash flow --0-240.00%-42K117.65%3K95.11%-32K--0---45K--30K---17K-24.49%-654K---95K
Financing cash flow
Cash flow from continuing financing activities 51,156.67%30.75M-98.53%316K9.80%11.02M82.12%38.61M-37.36%7M-99.32%60K21.51M10.04M9.32%21.2M11.18M
Net issuance payments of debt --19.73M--0--0--10M--0--0--0--10M--0--0
Net common stock issuance --48K302.00%303K--5.06M--6.85M--7M--0---150K--0--0--0
Net preferred stock issuance --------------0----------------327.07%21.12M--11.11M
Proceeds from stock option exercised by employees 19,113.33%11.53M-51.85%13K14,805.00%5.96M54.88%127K--0198.36%60K--27K--40K-21.36%82K--65K
Net other financing activities --------------21.64M--2K--0----------------
Cash from discontinued financing activities
Financing cash flow 51,156.67%30.75M-98.53%316K9.80%11.02M82.12%38.61M-37.36%7M-99.32%60K--21.51M--10.04M9.32%21.2M--11.18M
Net cash flow
Beginning cash position -79.83%4.51M28.24%13.21M69.97%14.3M-16.24%8.41M273.07%17.2M1,739.06%22.36M--10.3M--8.41M-33.54%10.05M--4.61M
Current changes in cash 554.16%23.48M-171.72%-8.65M-158.12%-1.1M460.94%5.89M-176.06%-2.89M-252.37%-5.17M--12.07M--1.88M67.84%-1.63M--3.81M
Effect of exchange rate changes 1,700.00%36K----------0--0--2K----------0--0
End cash Position 63.00%28.03M-79.83%4.51M28.24%13.21M69.97%14.3M69.97%14.3M273.07%17.2M--22.36M--10.3M-16.23%8.41M--8.41M
Free cash flow -39.08%-7.27M5.37%-8.97M-48.63%-12.12M-43.48%-32.76M-34.24%-9.9M2.90%-5.23M---9.48M---8.16M6.67%-22.83M---7.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data